Lakefront Biotherapeutics (LKFT) Net Margin (QoQ) (2016 - 2026)

Lakefront Biotherapeutics (LKFT) Net Margin (QoQ) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Lakefront Biotherapeutics 1.81 Bn -1.68 Bn 1.97 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 13,678.00
Dec 31, 2025 37,106.00
Sep 30, 2025 -12,242.00
Jun 30, 2025 4,279.00
Mar 31, 2025 -42,466.00
Dec 31, 2024 24,676.00
Sep 30, 2024 -915.00
Jun 30, 2024 -16,206.00
Mar 31, 2024 421.00
Dec 31, 2023 9,807.00
Sep 30, 2023 3,375.00
Jun 30, 2023 -3,114.00
Mar 31, 2023 15,425.00
Dec 31, 2022 -20,038.00
Sep 30, 2022 17,641.00
Jun 30, 2022 170.00
Mar 31, 2022 -6,828.00
Dec 31, 2021 249,723.00
Sep 30, 2021 -247,529.00
Jun 30, 2021 -4,603.00